Hemostats Market 2025 Growth Trends, Share - Global Analysis and Forecasts

Hemostats Market - Global Analysis and Forecasts By Product (Thrombin Based Hemostats, Combination Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Gelatin Based Hemostats, and Collagen Based Hemostats); End User (Hospitals & Clinics, Ambulatory Surgical Centers and Others)

Report Code: TIPHE100001419 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Hemostat is a surgical tool used to control bleeding in the surgical process. Hemostats are used by means of tissue sealants and tissue adhesion agents. These products are nowadays replacing conventional sutures for wound and incision closure. The tissue adhesives, tissue sealants, and related products has advantages such as application of minimal invasion, better visualization, reduced operating time, prevention of leakage of non-blood fluids and reduced post-operative infection risks and hence reduction in hospital stays and overall medical costs.

Rise in healthcare insurance providers, technological advancement and growing number of surgery procedures are expected to drive the growth of the market in the coming years. Rise in the untapped emerging nations and increased initiatives take up by governments is expected to offer growth opportunities for the manufacturers operating in the market during the forecast period.

The "Global Hemostats Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global hemostats market trend. The report aims to provide an overview of global hemostats market with detailed market segmentation by product, end user and geography. The global hemostats market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the hemostats market.

The global hemostats market is segmented on the basis of product and end user. Based on product, the hemostats market is categorized as, thrombin based hemostats, combination hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, and collagen based hemostats. On the basis on end user, the hemostats market is segmented as, hospitals & clinics, ambulatory surgical centers and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global hemostats market based on product and end user. It also provides market size and forecast till 2025 for overall hemostats market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America dominated the global hemostats market due to the increase in number of surgical procedures, technological advancements. However, the market in Asia-Pacific is anticipated to grow with the fastest rate during the forecast period due to increasing healthcare infrastructure along with rise in number of surgeries are propelling the growth of this market.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key hemostats manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Johnson & Johnson Services, Inc., C. R. Bard, Inc., Baxter, B. Braun Melsungen Ag, Pfizer Inc., Vascular Solutions, Inc., Gelita Medical Gmbh, Integra Lifesciences Holdings Corporation, Equimedical B.V., and Z-Medica, LLC among others.

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. HEMOSTATS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Hemostats Market - By Product
3.2.2. Hemostats Market - By End User
3.2.3. Hemostats Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. HEMOSTATS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. HEMOSTATS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL HEMOSTATS MARKET OVERVIEW
5.2. GLOBAL HEMOSTATS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS
6. HEMOSTATS MARKET- GLOBAL REGULATORY SCENARIO
6.1. OVERVIEW
6.2. NORTH AMERICA
6.3. EUROPE
6.4. ASIA PACIFIC
6.5. MIDDLE EAST & AFRICA
6.6. SOUTH AND CENTRAL AMERICA
7. HEMOSTATS MARKET REVENUE AND FORECASTS TO 2025 - BY PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. THROMBIN BASED HEMOSTATS MARKET
7.3.1. Overview
7.3.2. Thrombin Based Hemostats Market Revenue Forecasts and Analysis (US$ Mn)
7.4. COMBINATION HEMOSTATS MARKET
7.4.1. Overview
7.4.2. Combination Hemostats Market Revenue Forecasts and Analysis (US$ Mn)
7.5. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET
7.5.1. Overview
7.5.2. Oxidized Regenerated Cellulose Based Hemostats Market Revenue Forecasts and Analysis (US$ Mn)
7.6. GELATIN BASED HEMOSTATS MARKET
7.6.1. Overview
7.6.2. Gelatin Based Hemostats Market Revenue Forecasts and Analysis (US$ Mn)
7.7. COLLAGEN BASED HEMOSTATS MARKET
7.7.1. Overview
7.7.2. Collagen Based Hemostats Market Revenue Forecasts and Analysis (US$ Mn)
?
8. HEMOSTATS MARKET REVENUE AND FORECASTS TO 2025 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. HOSPITALS & CLINICS MARKET
8.3.1. Overview
8.3.2. Hospitals & Clinics Market Revenue Forecasts and Analysis (US$ Mn)
8.4. AMBULATORY SURGICAL CENTERS MARKET
8.4.1. Overview
8.4.2. Ambulatory Surgical Centers Market Revenue Forecasts and Analysis (US$ Mn)
8.5. OTHER END USERS MARKET
8.5.1. Overview
8.5.2. Other End Users Market Revenue Forecasts and Analysis (US$ Mn)

9. NORTH AMERICA HEMOSTATS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
9.1. NORTH AMERICA HEMOSTATS MARKET OVERVIEW
9.2. NORTH AMERICA HEMOSTATS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA HEMOSTATS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
9.4. NORTH AMERICA HEMOSTATS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.5. NORTH AMERICA HEMOSTATS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.6. US MARKET OVERVIEW
9.6.1. US Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.6.2. US Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.7. CANADA MARKET OVERVIEW
9.7.1. Canada Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.7.2. Canada Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
?
9.8. MEXICO MARKET OVERVIEW
9.8.1. Mexico Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.8.2. Mexico Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. EUROPE HEMOSTATS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
10.1. EUROPE HEMOSTATS MARKET OVERVIEW
10.2. EUROPE HEMOSTATS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE HEMOSTATS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
10.4. EUROPE HEMOSTATS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.5. EUROPE HEMOSTATS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.6. UK MARKET OVERVIEW
10.6.1. UK Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.6.2. UK Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.7. GERMANY MARKET OVERVIEW
10.7.1. Germany Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.7.2. Germany Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. FRANCE MARKET OVERVIEW
10.8.1. France Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.2. France Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11. ASIA PACIFIC HEMOSTATS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC HEMOSTATS MARKET OVERVIEW
11.2. ASIA PACIFIC HEMOSTATS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC HEMOSTATS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
11.4. ASIA PACIFIC HEMOSTATS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.5. ASIA PACIFIC HEMOSTATS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. JAPAN MARKET OVERVIEW
11.6.1. Japan Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.6.2. Japan Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.7. CHINA MARKET OVERVIEW
11.7.1. China Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.7.2. China Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. INDIA MARKET OVERVIEW
11.8.1. India Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.2. India Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. MIDDLE EAST AND AFRICA (MEA) HEMOSTATS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA HEMOSTATS MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA HEMOSTATS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA HEMOSTATS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.4. MIDDLE EAST AND AFRICA HEMOSTATS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.5. MIDDLE EAST AND AFRICA HEMOSTATS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.6. SOUTH AFRICA MARKET OVERVIEW
12.6.1. South Africa Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.6.2. South Africa Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.7. SAUDI ARABIA MARKET OVERVIEW
12.7.1. Saudi Arabia Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.7.2. Saudi Arabia Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. UAE MARKET OVERVIEW
12.8.1. UAE Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.8.2. UAE Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. SOUTH AND CENTRAL AMERICA HEMOSTATS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA HEMOSTATS MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA HEMOSTATS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA HEMOSTATS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA HEMOSTATS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA HEMOSTATS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.6. BRAZIL MARKET OVERVIEW
13.6.1. Brazil Hemostats Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.6.2. Brazil Hemostats Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions
?
15. HEMOSTATS MARKET, KEY COMPANY PROFILES
15.1. JOHNSON & JOHNSON SERVICES, INC.
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Product Pipeline
15.1.6. SWOT Analysis
15.1.7. Key Developments
15.2. C. R. BARD, INC.
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. Product Pipeline
15.2.6. SWOT Analysis
15.2.7. Key Developments
15.3. BAXTER
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. Product Pipeline
15.3.6. SWOT Analysis
15.3.7. Key Developments
15.4. B. BRAUN MELSUNGEN AG
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. Product Pipeline
15.4.6. SWOT Analysis
15.4.7. Key Developments
15.5. PFIZER INC.
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. Product Pipeline
15.5.6. SWOT Analysis
15.5.7. Key Developments
15.6. VASCULAR SOLUTIONS, INC.
15.6.1. Business Description
15.6.2. Financial Overview
15.6.3. Product Portfolio
15.6.4. Product Pipeline
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. GELITA MEDICAL GMBH
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. Product Pipeline
15.7.6. SWOT Analysis
15.7.7. Key Developments
15.8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. Product Pipeline
15.8.6. SWOT Analysis
15.8.7. Key Developments
15.9. EQUIMEDICAL B.V.
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. Product Pipeline
15.9.6. SWOT Analysis
15.9.7. Key Developments
15.10. Z-MEDICA, LLC
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. Product Pipeline
15.10.6. SWOT Analysis
15.10.7. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
The List of Companies

1. Johnson & Johnson Services, Inc.
2. C. R. Bard, Inc.
3. Baxter
4. B. Braun Melsungen Ag
5. Pfizer Inc.
6. Vascular Solutions, Inc.
7. Gelita Medical Gmbh
8. Integra Lifesciences Holdings Corporation
9. Equimedical B.V.
10. Z-Medica, LLC

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book